• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Lifestyle

Yuri Kwon, CEO of Raphas Co., Ltd.: “Microneedles Recognized as a Global Standard Production Platform”

The proprietary platform technologies of domestic biotech ventures have been selected one after another by Japan’s top-tier global manufacturing companies, which are known for their conservatism. The …
  • 2026-07-17 08:25:03
  • YU JIN-HEE
Technology

HLB Hits Limit-Up on FDA Optimism; Curiosis and Peptron Rebound Sharply [K-Bio Pulse]

On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains.Investor sentiment was buoyed by renewe…
  • 2026-07-17 08:11:03
  • Minji Son
Technology

Are Biotech Stocks Back in the Spotlight?… HLB INC. Hits Daily Limit Up, Curiosis Inc. and Peptron, Inc. Surge [Bio Market Watch]

On the 15th, in the domestic pharmaceutical and biotech stock market, while shares of the HLB INC.(028300) group all hit their daily price limits, #Curiosis Inc. and Peptron, Inc.(087010)showed strong…
  • 2026-07-17 08:11:01
  • Minji Son
Lifestyle

PenetriumBio Moves Directly to U.S. Phase 2 Clinical Trials... Incorporates a Three-Pronged Strategy to Boost Speed, Approval Rate, and Value

As #PenetriumBio, an innovative new drug development company, unveils its strategy to proceed directly to a U.S. Phase 2 clinical trial for “Penetrium”—its core pipeline candidate for treating intract…
  • 2026-07-16 11:01:02
  • YU JIN-HEE
Technology

Genomictree Inc. Kicks Off Commercialization of EarlyTec-B… Aims for the $5 Trillion U.S. Market

Genomictree Inc.(228760)is set to enter a phase of full-scale revenue generation following the approval of a deferral for the evaluation of its new medical technology, the bladder cancer molecular dia…
  • 2026-07-16 10:06:02
  • NA EUN-KYUNG
Technology

Choi Woo-sik, CEO of DEEPNOID Inc.: "Our Medical AI Foundation Model Has Surpassed Google's MedGemma"

“I was deeply impressed when I first encountered ‘ChatGPT’ in late 2022. Immediately afterward, we attempted a major pivot, shifting the company’s entire development strategy toward generative AI. ‘Me…
  • 2026-07-16 08:37:02
  • Kim Seung-kwon
Technology

The Final Hurdle for Physical AI Is the Operating Room… Korean Medical Robots Drawing Global Attention

While robot errors on the factory floor result in defective products, errors in the operating room are a matter of life and death. This is why the operating room stands as the final gateway—the one wi…
  • 2026-07-16 08:22:02
  • Hong Ju-yeon
Technology

Overcoming the Barriers of Visual Impairment... An Seong-wook, CEO of Renobit: The Story Behind His Mission to Hunt Down Cancer with Robotics and AI

"We are a company that uses robotics and artificial intelligence (AI) to address the reality where cancer goes undetected due to a shortage of personnel." Ahn Seong-wook, CEO of RINORBIT. (Image co…
  • 2026-07-16 08:11:02
  • Hong Ju-yeon
Technology

Hopes for Mifegyne Approval Boost Hyundai Pharm and Daehwa [K-Bio Pulse]

South Korea’s pharmaceutical and life sciences sectors saw broad declines on July 14.The pharmaceutical sector index fell 2.33% from the previous trading session. Of the 160 stocks in the sector, 41 r…
  • 2026-07-16 08:02:02
  • KIM JI-WAN
Lifestyle

“Will President Lee’s Remarks Lift the Ban on Mifegyn?”… Hyundai pharm Hits Daily Limit Up; DAE H WA PHARM CO., LTD., Which Holds a Stake, Also Surges [Bio Spotlight]

On the 14th, the domestic pharmaceutical and life sciences sectors showed a broad decline.The pharmaceutical sector index fell 2.33% from the previous trading day, with 41 of the 160 listed stocks ris…
  • 2026-07-16 08:01:02
  • KIM JI-WAN
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English